These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 26344623)

  • 21. Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 DNA candidate vaccine.
    Graham BS; Koup RA; Roederer M; Bailer RT; Enama ME; Moodie Z; Martin JE; McCluskey MM; Chakrabarti BK; Lamoreaux L; Andrews CA; Gomez PL; Mascola JR; Nabel GJ;
    J Infect Dis; 2006 Dec; 194(12):1650-60. PubMed ID: 17109336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced immunogenicity and protective efficacy of a tetravalent dengue DNA vaccine using electroporation and intradermal delivery.
    Williams M; Ewing D; Blevins M; Sun P; Sundaram AK; Raviprakash KS; Porter KR; Sanders JW
    Vaccine; 2019 Jul; 37(32):4444-4453. PubMed ID: 31279565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular mechanisms for enhanced DNA vaccine immunogenicity.
    Li L; Petrovsky N
    Expert Rev Vaccines; 2016; 15(3):313-29. PubMed ID: 26707950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human Immunodeficiency Virus C.1086 Envelope gp140 Protein Boosts following DNA/Modified Vaccinia Virus Ankara Vaccination Fail To Enhance Heterologous Anti-V1V2 Antibody Response and Protection against Clade C Simian-Human Immunodeficiency Virus Challenge.
    Styles TM; Gangadhara S; Reddy PBJ; Hicks S; LaBranche CC; Montefiori DC; Derdeyn CA; Kozlowski PA; Velu V; Amara RR
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31341049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancing immune responses against HIV-1 DNA vaccine by coinoculating IL-6 expression vector.
    Jiang W; Jin N; Cui S; Li Z; Zhang L; Wang H; Han W
    J Virol Methods; 2006 Sep; 136(1-2):1-7. PubMed ID: 16793146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity and efficacy of DNA/MVA HIV vaccines in rhesus macaque models.
    Chea LS; Amara RR
    Expert Rev Vaccines; 2017 Oct; 16(10):973-985. PubMed ID: 28838267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The site of administration influences both the type and the magnitude of the immune response induced by DNA vaccine electroporation.
    Vandermeulen G; Vanvarenberg K; De Beuckelaer A; De Koker S; Lambricht L; Uyttenhove C; Reschner A; Vanderplasschen A; Grooten J; Préat V
    Vaccine; 2015 Jun; 33(28):3179-85. PubMed ID: 25980430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vector Design for Improved DNA Vaccine Efficacy, Safety and Production.
    Williams JA
    Vaccines (Basel); 2013 Jun; 1(3):225-49. PubMed ID: 26344110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Genetic Adjuvants Interleukin-12 and Granulocyte-Macrophage Colony Stimulating Factor Enhance the Immunogenicity of an Ebola Virus Deoxyribonucleic Acid Vaccine in Mice.
    Suschak JJ; Bagley K; Shoemaker CJ; Six C; Kwilas S; Dupuy LC; Schmaljohn CS
    J Infect Dis; 2018 Nov; 218(suppl_5):S519-S527. PubMed ID: 30053157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasmid DNA vaccines: where are we now?
    Ghaffarifar F
    Drugs Today (Barc); 2018 May; 54(5):315-333. PubMed ID: 29911696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Priming with plasmid DNAs expressing interleukin-12 and simian immunodeficiency virus gag enhances the immunogenicity and efficacy of an experimental AIDS vaccine based on recombinant vesicular stomatitis virus.
    Egan MA; Chong SY; Megati S; Montefiori DC; Rose NF; Boyer JD; Sidhu MK; Quiroz J; Rosati M; Schadeck EB; Pavlakis GN; Weiner DB; Rose JK; Israel ZR; Udem SA; Eldridge JH
    AIDS Res Hum Retroviruses; 2005 Jul; 21(7):629-43. PubMed ID: 16060834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA vaccination of macaques by a full genome HIV-1 plasmid which produces noninfectious virus particles.
    Akahata W; Ido E; Shimada T; Katsuyama K; Yamamoto H; Uesaka H; Ui M; Kuwata T; Takahashi H; Hayami M
    Virology; 2000 Sep; 275(1):116-24. PubMed ID: 11017793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergistic enhancement of immunogenicity and protection in mice against Schistosoma japonicum with codon optimization and electroporation delivery of SjTPI DNA vaccines.
    Zhu Y; Lu F; Dai Y; Wang X; Tang J; Zhao S; Zhang C; Zhang H; Lu S; Wang S
    Vaccine; 2010 Jul; 28(32):5347-55. PubMed ID: 20483191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The combination of TLR-9 adjuvantation and electroporation-mediated delivery enhances in vivo antitumor responses after vaccination with HPV-16 E7 encoding DNA.
    Ohlschläger P; Spies E; Alvarez G; Quetting M; Groettrup M
    Int J Cancer; 2011 Jan; 128(2):473-81. PubMed ID: 20309939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV Env conserved element DNA vaccine alters immunodominance in macaques.
    Hu X; Valentin A; Rosati M; Manocheewa S; Alicea C; Chowdhury B; Bear J; Broderick KE; Sardesai NY; Gall SL; Mullins JI; Pavlakis GN; Felber BK
    Hum Vaccin Immunother; 2017 Dec; 13(12):2859-2871. PubMed ID: 28678607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intradermal SynCon® Ebola GP DNA Vaccine Is Temperature Stable and Safely Demonstrates Cellular and Humoral Immunogenicity Advantages in Healthy Volunteers.
    Tebas P; Kraynyak KA; Patel A; Maslow JN; Morrow MP; Sylvester AJ; Knoblock D; Gillespie E; Amante D; Racine T; McMullan T; Jeong M; Roberts CC; Park YK; Boyer J; Broderick KE; Kobinger GP; Bagarazzi M; Weiner DB; Sardesai NY; White SM
    J Infect Dis; 2019 Jul; 220(3):400-410. PubMed ID: 30891607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved humoral and cellular immune responses against the gp120 V3 loop of HIV-1 following genetic immunization with a chimeric DNA vaccine encoding the V3 inserted into the hepatitis B surface antigen.
    Fomsgaard A; Nielsen HV; Bryder K; Nielsen C; Machuca R; Bruun L; Hansen J; Buus S
    Scand J Immunol; 1998 Apr; 47(4):289-95. PubMed ID: 9600309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electroporation in DNA vaccination protocols against cancer.
    Chiarella P; Fazio VM; Signori E
    Curr Drug Metab; 2013 Mar; 14(3):291-9. PubMed ID: 23116110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toxicological safety evaluation of DNA plasmid vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile virus is similar despite differing plasmid backbones or gene-inserts.
    Sheets RL; Stein J; Manetz TS; Andrews C; Bailer R; Rathmann J; Gomez PL
    Toxicol Sci; 2006 Jun; 91(2):620-30. PubMed ID: 16569728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement of the immunogenicity of an alphavirus replicon-based DNA vaccine against classical swine fever by electroporation and coinjection with a plasmid expressing porcine interleukin 2.
    Tian DY; Sun Y; Wai SF; Lee FK; Meng QL; Suen KM; Wang N; Han W; Li S; Li YF; Li D; Ling LJ; Liao YJ; Qiu HJ
    Vaccine; 2012 May; 30(24):3587-94. PubMed ID: 22469861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.